Efficacy and safety of cyclosporine and steroid for the treatment of minimal change nephrotic syndrome
Not Applicable
- Conditions
- Minimal change nephrotic syndrome
- Registration Number
- JPRN-UMIN000000963
- Lead Sponsor
- Yoshihiko Saito
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
Cr>=2.0mg/dl or eGFR<50 Malignancy Uncontrolled hypertension Seizure disorder Pregnant women Infection Severe cardiac, hepatic or pancreatic disease Alelrgy to cyclosporine
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Rate for complete remission Total dose of steroid Duration of admission
- Secondary Outcome Measures
Name Time Method